Malignant Mesothelioma — Trials

Malignant Mesothelioma — Trials · CancerIndex

Clinical trials

Registered studies

478 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 96
Recruiting: 55
Ph III recruiting: 1
Growth YoY: —
Industry share: 38%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.4%
Trials / 1,000 deaths: 45.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (81)

clinicaltrialsPublishedShowing 51–60 of 60 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00996385	Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma	unknown	Phase 2	29	Columbia UniversityOTHER	1	Oct 31, 2011	clinicaltrials
NCT01343264	Trimodality Therapy for Malignant Pleural Mesothelioma	unknown	—	200	HSK WiesbadenOTHER	1	Apr 28, 2011	clinicaltrials
NCT01281800